Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy

BACKGROUND: PCA3 has been included in a nomogram outperforming previous clinical models for the prediction of any prostate cancer (PCa) and high grade PCa (HGPCa) at the initial prostate biopsy (IBx). Our objective is to validate such IBx-specific PCA3-based nomogram. We also aim to optimize the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio-Briones, Jose, Borque, Angel, Esteban, Luis M., Casanova, Juan, Fernandez-Serra, Antonio, Rubio, Luis, Casanova-Salas, Irene, Sanz, Gerardo, Domínguez-Escrig, Jose, Collado, Argimiro, Gómez-Ferrer, Alvaro, Iborra, Inmaculada, Ramírez-Backhaus, Miguel, Martínez, Francisco, Calatrava, Ana, Lopez-Guerrero, Jose A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567811/
https://www.ncbi.nlm.nih.gov/pubmed/26362197
http://dx.doi.org/10.1186/s12885-015-1623-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567811/
https://www.ncbi.nlm.nih.gov/pubmed/26362197
http://dx.doi.org/10.1186/s12885-015-1623-0

Ejemplares similares